| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-07 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |